Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envafolimab Combined With GEMOX in Advanced Gallbladder Cancer
NCT06013943Phase 2Recruiting
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Mar 2023
- Primary completion
- May 2025
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of envafolimab in gallbladder cancer, sponsored by Eastern Hepatobiliary Surgery Hospital. Started Mar 2023; status: recruiting.
02
Drugs
envafolimab
03
Conditions
gallbladder cancer
Beyond the preview
Go deeper on NCT06013943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06013943.